SCHEMBL1825869

SCHEMBL1825869

CC(C)(C)OC(=O)[C@H](Cc1cccc(OS(C)(=O)=O)c1)NC(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.49
P2RX7 Q99572 8/20 0.48
CTSB P07858 3/20 0.47
CTSS P25774 3/20 0.47
CTSL P07711 3/20 0.47
CTSK P43235 3/20 0.46
ITGB3 P05106 2/20 0.46
ITGA2B P08514 2/20 0.46
ALDH1A1 P00352 1/20 0.45
ALOX15 P16050 1/20 0.45
PSMB5 P28074 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824246 0.92 CTSS (0.50) SYKCTSBCTSSCTSLCTSK
SCHEMBL1825260 0.91 CTSS (0.49) CTSBCTSSCTSLCTSK
SCHEMBL1824760 0.90 P2RX7 (0.57) SYKP2RX7CTSBCTSSCTSL
SCHEMBL1826580 0.90 P2RX7 (0.58) SYKP2RX7CTSBCTSSCTSL
SCHEMBL1826579 0.90 P2RX7 (0.58) SYKP2RX7CTSBCTSSCTSL
SCHEMBL1826360 0.90 ALDH1A1 (0.54) CTSBCTSSCTSLCTSKALDH1A1
SCHEMBL1824920 0.88 CTSL (0.48) P2RX7CTSBCTSSCTSLCTSK
SCHEMBL1827997 0.87 P2RX7 (0.64) P2RX7CTSBCTSSCTSL
SCHEMBL1826413 0.87 CTSL (0.48) CTSBCTSSCTSLCTSKALDH1A1
SCHEMBL1824980 0.86 TACR1 (0.43) CTSBCTSSCTSLCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2161254-B1 Intermediate for preparing a biaryl compound SUMITOMO CHEMICAL CO (JP) 2014-08-13 EP disclosed
EP-1481967-B1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS SUMITOMO CHEMICAL CO (JP) 2011-05-04 EP disclosed
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
EP-2161254-A1 Intermediate for preparing a biaryl compound Sumitomo Chemical Company, Limited (JP) 2010-03-10 EP disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
EP-1481967-A1 PROCESS FOR THE PREPARATION OF BIARYL COMPOUNDS Sumitomo Chemical Company, Limited (JP) 2004-12-01 EP disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 SYK 1520/4885P2RX7 3606/4885CTSB 2746/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 SYK 1172/4885P2RX7 2747/4885CTSB 496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.